Get started
Author

Laëtitia Belgodère

Observed names: L. Belgodere, Laetitia Belgodere, Laetitia Belgodère
ORCID: 0000-0002-7408-2761
Observed ORCID: 0000-0002-7408-2761
OpenAlex ID: A5037048049
Regulatory assessment of nano-enabled health products in public health interest. Position of the scientific advisory board of the French National Agency for the Safety of Medicines and Health Products
2023 · Wahiba Oualikene-Gonin, Valérie Sautou, et al. · Frontiers in Public Health · 60
PDF
Artificial intelligence integration in the drug lifecycle and in regulatory science: policy implications, challenges and opportunities
2024 · Wahiba Oualikene-Gonin, Marie-Christine Jaulent, et al. · Frontiers in Pharmacology · 53
PDF
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
2021 · Emmanuelle Jacquet, Ghania Kerouani-Lafaye, et al. · European Journal of Cancer · 21
PDF
Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience
2023 · Laëtitia Belgodère, Joseph Emmerich, et al. · Frontiers in Public Health · 18
PDF
Access to innovation through the national early access program and clinical trials for patients with malignant melanoma
2021 · Claire Christen, Laetitia Belgodère, et al. · Cancer · 9
Patient and public involvement in the benefit–risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM)
2023 · Laëtitia Belgodère, Dominique Pougheon Bertrand, et al. · BMJ Global Health · 8
PDF
Evaluation of Clinical Trials in Onco-haematology: A New Method Based on Risk Analysis and Multidisciplinarity
2021 · J. Lapière, C. Christen, et al. · Therapeutic Innovation & Regulatory Science · 1
Bedside to benchmark: Evidence-based medicine inspires evidence-based regulation of medicines
2026 · Trystan Bacon, Pascale Daynès, et al. · Therapies
Age and sex disparities in drug shortage impacts: a 10-year nationwide study in France
2026 · Laëtitia Belgodère, Christopher Leleu, et al. · European Journal of Public Health
Concilier régulation du médicament et démocratie sanitaire : rôle des conseillers patient ou professionnel de santé à l’ANSM
2024 · Patrick Maison, Trystan Bacon, et al. · Therapies
Access to innovation through the French Expanded-Access Program and clinical trials in patients with malignant melanoma.
2020 · Claire Christen, Laetitia Belgodere, et al. · Journal of Clinical Oncology
Works count: 11
Citation count: 170
H-index: 6
I10-index: 4
Year
Topic
Type